The monthly research advisory that gives subscribers access to venture capital-like opportunities in the stock market.
Editor Dave Lashmet looks for investments similar to the type available to the largest venture-capital firms, which make billions of dollars in profits by funding companies like Facebook and Twitter in their infancy…

About Stansberry Venture Technology

In Stansberry Venture Technology, Dave Lashmet scours the public markets for little-known, small-cap companies that are producing the next wonder drug or technology. And you can access these opportunities even if you’re not a millionaire or a venture capitalist.

Dave is the perfect man to head up this effort. He is extremely plugged in to the technology and biotech sector. He’s an inventor with three active patents. He has developed, packaged, and sold his ideas to one of the largest consumer-electronics firms in the world.

He has also spent the last 20-plus years working as an independent technology analyst, and close to a decade researching and writing about technology at five major universities.

In Stansberry Venture Technology, Dave searches for the smallest and most promising firms out there… ones you’d likely never hear about (that is, until they get acquired). The goal is for subscribers to make five or 10 times their money on these speculations.

Portfolio Snapshot
Number of Positions
Approx. 15-25
Safety

Lower

Higher

*Number of positions, safety, and returns may vary. These are estimates based upon our track record and historical data.
Publication Overview
How often is this service published?
Monthly (fourth Tuesday of every month) with e-mail updates as needed
How much capital should I have to get started?
Minimum of $50,000
What will we be buying?
Stocks
Do you put on short trades?
No
What’s a typical holding period?
12 months to 3 years, and often longer
David Lashmet
Editor
David Lashmet
John Engel
Analyst
John Engel
Bill McGilton
Analyst
Bill McGilton
About The Editor

Dave Lashmet is editor of Stansberry Venture Technology, an advisory service focused on the most important trend in the world – emerging technologies. He takes a "venture capitalist" approach to investing... seeking out small-cap speculative stocks with strong catalysts and outstanding breakout growth potential.

Dave undertakes intensive research to discover under-the-radar technology and medical companies with stunning catalysts for near-term growth. The stocks recommended in Stansberry Venture Technology have the potential to double and triple in price.

He is also a senior analyst to Stansberry's Investment Advisory.

Presentation Image
“I just wanted to say thank you Dave to you and your whole team. That write-up was so well researched and presented, I couldn't help but participate in that great opportunity! I never would have found this small company on my own. Looking forward to more big wins in the coming years.”

– James E. Subscriber of Stansberry Venture Technology

Call Today
Contact a customer service representative to learn more.
(888) 863-9356
This service is not available for purchase online. Please call for details.
Back to Top